Molecular Partners Ag (MOLN) Profit After Tax (2020 - 2026)

Molecular Partners Ag (MOLN) posted quarterly Profit After Tax of -$16784.9 for Q1 2026, up 10.02% year-on-year from -$15256.6 in Q1 2025, and up 99.98% on a QoQ basis from -$77.1 million in Q4 2025.

Molecular Partners Ag (MOLN) Profit After Tax (2020 - 2026) Analysis & Trends

Molecular Partners Ag (MOLN) has reported Profit After Tax for 7 consecutive years, with -$16784.9 the latest figure, recorded in Q1 2026.

  • Quarterly Profit After Tax rose 10.02% year-over-year to -$16784.9 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$77.2 million (down 214.24% YoY) and the FY2025 annual result came in at -$77.2 million, down 214.23% from the prior year.
  • Profit After Tax grew to -$16784.9 in Q1 2026 per MOLN's latest filing, from -$77.1 million in the prior quarter.
  • Over the last five years, Profit After Tax for MOLN reached as high as $122.2 million in Q4 2022 and fell as low as -$77.1 million in Q4 2025.
  • A 5-year average of $1.2 million and a median of -$16677.6 in 2024 frame the typical range for Profit After Tax.
  • Annual changes were most pronounced in 2022 — Profit After Tax surged 1020.39% — and 2023, when it sank 278.7%.
  • Year by year, Profit After Tax stood at $122.2 million in 2022, then slumped by 157.15% to -$69.8 million in 2023, then jumped by 196.85% to $67.6 million in 2024, then plunged by 214.06% to -$77.1 million in 2025, then soared by 99.98% to -$16784.9 in 2026.
  • According to Business Quant data, Profit After Tax over the past three periods registered -$16784.9, -$77.1 million, and -$15258.8 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -36.84 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 227.36 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.03 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -65.60 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -26.94 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 362.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -453.82 Mn
10 Molecular Partners Ag 147.97 Mn 147.97 Mn - -16,784.95

Historic Data

Download Data
DateValue
Mar 31, 2026 -16,784.95
Dec 31, 2025 -77.14 Mn
Sep 30, 2025 -15,258.84
Jun 30, 2025 -27,182.36
Mar 31, 2025 -18,653.55
Dec 31, 2024 67.63 Mn
Sep 30, 2024 -20,607.22
Jun 30, 2024 -16,677.58
Mar 31, 2024 -12,974.85
Dec 31, 2023 -69.83 Mn
Sep 30, 2023 -12,950.69
Jun 30, 2023 -17.78 Mn
Mar 31, 2023 -15,977.42
Dec 31, 2022 122.19 Mn
Sep 30, 2022 -15,424.16
Jun 30, 2022 -4.70 Mn
Mar 31, 2022 168,520.72
Dec 31, 2021 -69.13 Mn
Sep 30, 2021 -13,406.09
Jun 30, 2021 -36.79 Mn